CVS-Aetna remedy is still the right course, DOJ tells court after reviewing public comments
MLex Summary: The divestiture of Aetna's standalone Medicare Part D prescription drug business to address concerns in the CVS Health-Aetna deal is still the right choice to address concerns, the US...To view the full article, register now.
Already a subscriber? Click here to view full article